News

Jenner & Block Japan Newsletter - April 2025

By EsqSocial Corporation 05/05/25

Welcome to the April 2025 edition of the Jenner & Block Japan Newsletter, a publication containing updates about legal developments in the United States that may be noteworthy to our clients and other leaders in the Japanese legal and business communities....

Is Arbitration Right for Your Legal Needs? Key Considerations Before Choosing Arbitration Over Litigation

By EsqSocial Corporation 05/05/25

Arbitration is often viewed as a faster, more cost-effective alternative to litigation, but is it the right choice for every dispute? Should you include an arbitration clause in every contract?

BVI Corporate Review – Q1 2025

By EsqSocial Corporation 05/05/25

Welcome to the first 2025 edition of our quarterly BVI Corporate Review. The first quarter of 2025 saw continued strong activity in the BVI.

Reflections on the Inflation Reduction Act’s Pill Penalty

By EsqSocial Corporation 05/05/25

The Medicare drug price negotiation provision in the 2022 Inflation Reduction Act treats small molecule drugs and biological products differently.

IRS Announces HSA and HDHP Limits for 2026

By EsqSocial Corporation 05/05/25

The Internal Revenue Service has released Rev. Proc. 2025-19 announcing the inflation-adjusted limits for high deductible health plans (HDHPs) and health savings accounts (HSAs) in 2026.  The updated 2026 limits are as follows......

Legislative Top 5 – May 2025

By EsqSocial Corporation 05/05/25

State of Affairs - With the constitutionally-mandated end of session just over two weeks away (Monday, May 19), much work remains to be done in order to pass a two-year budget.

Big, Beautiful and Really Terrific: Government Contracting in the Trump Administration

By EsqSocial Corporation 05/05/25

After 100 days, the dawn of the Trump administration reveals to contractors a variable horizon. Changes to the procurement process and shifting budget priorities threaten certain contracts.

Is Delaware Forum Selection Bylaw Binding On Shareholder Who Filed Suit When The Corporation Was Incorporated In California?

By EsqSocial Corporation 05/05/25

In Drulias v. 1st Century Bancshares, Inc. 30 Cal. App.

[Video] Daily Compliance News: May 5, 2025, The Washing Edition

By EsqSocial Corporation 05/05/25

Welcome to the Daily Compliance News. Each day, Tom Fox, the Voice of Compliance, brings you compliance-related stories to start your day. Sit back, enjoy morning coffee, and listen to the Daily Compliance News. All, from the Compliance Podcast Network.

Humira® Biosimilar Yuflyma® (adalimumab-aaty) Designated as Interchangeable

By EsqSocial Corporation 04/05/25

On April 14, 2025, Celltrion announced that the FDA designated Yuflyma® (adalimumab-aaty) as an interchangeable biosimilar of AbbVie’s Humira® (adalimumab). Yuflyma® is a high-concentration (100mg/mL) citrate-free formulation, which accounts for about 85% of adalimumab prescriptions....

Pages